Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin
Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin
OBJECTIVE: To determine if Meglumine-Eicosapentaenoic Acid (MeEPA) acts synergistically with epirubicin and mitomycin to enhance cytotoxicity towards bladder cancer cell lines in vitro.
MATERIALS AND METHODS: Bladder cancer cells were exposed to MeEPA in combination with epirubicin or mitomycin. Residual viable cell biomass was estimated with the methyl-thiazoldiphenyl tetrazolium (MTT) assay following drug exposure. Drug interaction was analysed using median effect analysis to determine levels of synergism.
RESULTS: Most combinations of MeEPA with both epirubicin and mitomycin showed a high-level of synergism. At high doses, drug precipitation adversely affected MTT assay analysis suggesting antagonism of action. However, the predominant pattern was of synergism for most dose combinations tested.
CONCLUSION: Bladder cancer treated by endoscopic resection alone is subject to high recurrence rates. Post-operative intravesical instillation of epirubicin and mitomycin can halve recurrence rates, but there is no evidence that disease progression to invasive bladder cancer is altered. Thus, optimisation of current treatment strategies is required. The anti-tumour activity of fatty acids is well established and MeEPA is a new, soluble formulation with the potential to enhance intravesical drug efficacy.
367-373
Mackie, S.J.
c5c45fba-87e6-4500-812c-ecd8fdbc8989
Sharma, D.M.
d235d81b-b8e1-41d7-976a-1301c4fa9fee
Cooper, A.J.
8a21c297-eda3-4479-8e81-1de258c8e2a1
Harris, N.M.
39ad8cbe-4ca3-438c-b496-ee2e805382be
Lwaleed, B.A.
e7c59131-82ad-4a14-a227-7370e91e3f21
December 2006
Mackie, S.J.
c5c45fba-87e6-4500-812c-ecd8fdbc8989
Sharma, D.M.
d235d81b-b8e1-41d7-976a-1301c4fa9fee
Cooper, A.J.
8a21c297-eda3-4479-8e81-1de258c8e2a1
Harris, N.M.
39ad8cbe-4ca3-438c-b496-ee2e805382be
Lwaleed, B.A.
e7c59131-82ad-4a14-a227-7370e91e3f21
Mackie, S.J., Sharma, D.M., Cooper, A.J., Harris, N.M. and Lwaleed, B.A.
(2006)
Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin.
Prostaglandins, Leukotrienes and Essential Fatty Acids, 75 (6), .
(doi:10.1016/j.plefa.2006.07.002).
(PMID:16930970)
Abstract
OBJECTIVE: To determine if Meglumine-Eicosapentaenoic Acid (MeEPA) acts synergistically with epirubicin and mitomycin to enhance cytotoxicity towards bladder cancer cell lines in vitro.
MATERIALS AND METHODS: Bladder cancer cells were exposed to MeEPA in combination with epirubicin or mitomycin. Residual viable cell biomass was estimated with the methyl-thiazoldiphenyl tetrazolium (MTT) assay following drug exposure. Drug interaction was analysed using median effect analysis to determine levels of synergism.
RESULTS: Most combinations of MeEPA with both epirubicin and mitomycin showed a high-level of synergism. At high doses, drug precipitation adversely affected MTT assay analysis suggesting antagonism of action. However, the predominant pattern was of synergism for most dose combinations tested.
CONCLUSION: Bladder cancer treated by endoscopic resection alone is subject to high recurrence rates. Post-operative intravesical instillation of epirubicin and mitomycin can halve recurrence rates, but there is no evidence that disease progression to invasive bladder cancer is altered. Thus, optimisation of current treatment strategies is required. The anti-tumour activity of fatty acids is well established and MeEPA is a new, soluble formulation with the potential to enhance intravesical drug efficacy.
This record has no associated files available for download.
More information
e-pub ahead of print date: 23 August 2006
Published date: December 2006
Organisations:
Faculty of Health Sciences
Identifiers
Local EPrints ID: 348739
URI: http://eprints.soton.ac.uk/id/eprint/348739
PURE UUID: 485d4e31-6e5f-4e6e-b31d-c0ceed8924b4
Catalogue record
Date deposited: 18 Feb 2013 16:52
Last modified: 06 Aug 2024 01:39
Export record
Altmetrics
Contributors
Author:
S.J. Mackie
Author:
D.M. Sharma
Author:
A.J. Cooper
Author:
N.M. Harris
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics